Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1993-10-21
1997-10-14
Raymond, Richard L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514544, 514545, 514676, 514683, 514684, 514719, 514727, 514728, 514731, 514741, A61K 3104, A61K 3105, A61K 31085, A61K 3112
Patent
active
056773366
ABSTRACT:
Non-steroidal compounds which are high affinity, high specificity ligand antagonists for the androgen receptor are disclosed. Also disclosed are methods for employing the disclosed compounds for modulating processes mediated by the androgen receptor and for treating patients requiring androgen receptor antagonist therapy.
REFERENCES:
patent: 1593080 (1926-07-01), Jordan
patent: 4778621 (1988-10-01), Isoyama et al.
patent: 4981784 (1991-01-01), Evans et al.
patent: 5017610 (1991-05-01), Imaki et al.
patent: 5071773 (1991-12-01), Evans et al.
patent: 5128479 (1992-07-01), Janssen et al.
patent: 5134155 (1992-07-01), Connolly et al.
patent: 5135940 (1992-08-01), Belanger et al.
S. Antus et al, Tetrahedron, 42 (20):5637-5640 (1986).
S. Aoki et al, J. Am. Chem. Soc., 110 (10):3296-3298 (May 11, 1988).
J. Chakravarty et al, Proc. Indian Academy of Sciences, Section A, 86A (3):317-325 (1977).
A.I. Chirko et al, Chemical Abstracts, 66 (21):8859, Abstract No. 94773s (May 22, 1967).
K. Das Gupta, J. Indian Chemical Soc., 42(5):415-423 (1969).
C. Destabel et al, J. Chem. Soc., Chemical Communications, 8:596-568 (Apr. 15, 1992).
K. Laumen et al, J. Chem. Soc., Chemical Communictions, 1:49-51 (Jan. 1990).
M. Moreau et al, Bulletin de la Societe Chimique de France, 4:1362-1367 (1969).
H. Nagano et al, Bulletin of the Chemical Society of Japan, 65(9):2421-2426 (Sep. 1992).
K. Narasaka et al, Tetrahedron, 48(11):2059-2068 (Mar. 13, 1992).
K. Narasaka et al, Chemistry Letters, 8:1413-1416 (1991).
S. Pal et al, J. Chem. Soc., Chemical Communications, 22:1591-1593 (Nov. 15, 1991).
J.L. Reymond et al, J. Am. Chem. Soc., 115(10):3909-3917 (May 19, 1993).
J.P. Yardley et al, Experientia, 34(9):1124-1125 (Sep. 15, 1978).
Riemschneider et al, Chemical Abstracts, vol. 78 (1973) 77564e.
Bolysheva et al, Chemical Abstracts, vol. 78 (1973) 42981m.
Rang et al, Chemical Abstracts, vol. 89 (1978) 162644c.
Pirkle et al, Chemical Abstracts, vol. 95 (1981) 42191e.
Agirbas et al, Chemical Abstracts, vol. 104 (1986) 207396v.
Kurusu et al, Chemical Abstracts, vol. 108 (1988) 130806b.
Gohndrone et al, Chemical Abstracts, vol. 117 (1992) 131372e.
Banik, B. K. et al., J. Chem. Research(S), pp. 406-407, 1986.
Berry, N. M. et al., Synthesis, pp. 476-480, Jun. 1986.
Pal, S. et al., Synthesis, pp. 1073-1075, Nov. 1992.
Tanaka et al., Agric. Biol. Chem., 54(1), 1990, pp. 121-123.
Berger, T. et al., J. Steroid Biochem. Molec. Biol., 41:773 (1992).
Evans, R.M., Science, 240:889-95 (May 13, 1988).
Hogberg, H. and Thomson, R.H., J. Chem. Soc. Perkin Trans. 1, pp. 1696-1701 (1976).
McConnell, O.J. et al., Phytochemistry, 21:2139-41 (1982).
Wall, M.E., et al., J. of Natl. Prod., 52:1092-99 (Sep.-Oct. 1989).
Farmer Luc
Goldman Mark E.
Hamann Lawrence G.
Johnson Michael G.
Jones Todd K.
Ligand Pharmaceuticals Incorporated
Raymond Richard L.
LandOfFree
Non-steroid androgen receptor antagonist compounds and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-steroid androgen receptor antagonist compounds and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-steroid androgen receptor antagonist compounds and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1555800